David Hyun, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Offices
- 3
Offices
3 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hyun’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A56256 · Current
Licensed to practise in California · since 1996 · expires 2028-01-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$262,282
Medicare paid this office $262,282 for 642 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 512 | $162,768 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $34,802 | $198 |
| New patient visit (60+ min) | 101 | $18,749 | $186 |
| Transitional care management services for problem of high complexity | 34 | $10,427 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $8,757 | $114 |
See all 17 services
| Long return visit (40+ min) | 512 | $162,768 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $34,802 | $198 |
| New patient visit (60+ min) | 101 | $18,749 | $186 |
| Transitional care management services for problem of high complexity | 34 | $10,427 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $8,757 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $4,788 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $4,419 | $74 |
| Programming of dual lead pacemaker system | 30 | $3,720 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,651 | $166 |
| Transitional care management services for problem of at least moderate complexity | 12 | $2,847 | $219 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $1,832 | $76 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 29 | $859 | $30 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 12 | $437 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $368 | $28 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $318 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $212 | $14 |
| Heart rhythm recording of continous external ekg over 8-15 days | 14 | $153 | $11 |
Who their Medicare patients are
642 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 24% · Women 56% · Also on Medicaid 20% · Health risk score 1.53. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 43% · Heart failure 33% · Chronic kidney disease 33% · Atrial fibrillation 33% · Depression 20% · Cancer 19% · COPD 18% · Stroke 17% · Dementia 10%.
The office billed $522,853, Medicare allowed $357,089 and paid $262,282; for 1,832 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 642 | 1,832 | 78 | 1.53 | $522,853 | $262,282 |
| 2023 | 787 | 2,547 | 77 | 1.76 | $539,275 | $301,894 |
| 2022 | 771 | 3,768 | 78 | 1.77 | $715,199 | $336,925 |
| 2021 | 924 | 7,153 | 78 | 2.07 | $1,899,452 | $503,906 |
| 2020 | 801 | 5,549 | 79 | 1.97 | $1,524,825 | $386,008 |
| 2019 | 963 | 5,778 | 79 | 2.14 | $1,976,946 | $458,045 |
| 2018 | 1,124 | 6,433 | 80 | 2.35 | $1,991,080 | $597,171 |
| 2017 | 1,180 | 6,497 | 80 | 2.24 | $1,962,577 | $629,049 |
| 2016 | 1,202 | 7,536 | 80 | 2.23 | $1,292,631 | $638,079 |
| 2015 | 1,095 | 7,550 | 81 | 2.05 | $1,079,711 | $583,859 |
| 2014 | 959 | 6,749 | 81 | 1.76 | $954,057 | $508,438 |
| 2013 | 807 | 5,318 | 79 | 1.81 | $874,146 | $467,426 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Long return visit (40+ min) | 514 | $160,376 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $36,000 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $24,442 | $110 |
| New patient visit (60+ min) | 123 | $22,864 | $186 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 224 | $14,219 | $62 |
| Transitional care management services for problem of high complexity | 40 | $11,581 | $276 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $7,197 | $156 |
| Programming of dual lead pacemaker system | 33 | $4,920 | $83 |
| Transitional care management services for problem of at least moderate complexity | 20 | $3,917 | $187 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,993 | $71 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $1,889 | $76 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 30 | $1,242 | $6 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 36 | $1,223 | $31 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 42 | $981 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 42 | $483 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $379 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $253 | $13 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 17 | $228 | $11 |
2022: 24 services
| Long return visit (40+ min) | 539 | $168,312 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $30,043 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $27,348 | $94 |
| New patient visit (60+ min) | 110 | $20,382 | $185 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $14,500 | $500 |
| Transitional care management services for problem of high complexity | 45 | $13,882 | $272 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $11,762 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $11,487 | $177 |
| Programming of dual lead pacemaker system | 38 | $5,865 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $5,015 | $66 |
| Transitional care management services for problem of at least moderate complexity | 20 | $4,310 | $205 |
| Return visit (30+ min) | 35 | $3,598 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,555 | $69 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 40 | $1,908 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $1,896 | $76 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 46 | $1,707 | $32 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 50 | $1,254 | $25 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $789 | $72 |
| Heart rhythm recording of continous external ekg over 8-15 days | 50 | $675 | $14 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 40 | $510 | $10 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 24 | $427 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $314 | $14 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 12 | $217 | None |
| Infusion, normal saline solution, 250 cc | 30 | $116 | None |
2021: 25 services
| Return visit (30+ min) | 408 | $78,255 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 278 | $77,407 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 334 | $70,075 | $175 |
| Long return visit (40+ min) | 306 | $67,266 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 328 | $50,514 | $95 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 71 | $36,128 | $509 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $34,803 | $208 |
| New patient visit (60+ min) | 118 | $22,376 | $190 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 67 | $12,941 | $98 |
| Transitional care management services for problem of high complexity | 29 | $9,138 | $277 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $8,765 | $65 |
| Transitional care management services for problem of at least moderate complexity | 33 | $7,471 | $192 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 223 | $6,064 | $6 |
| Programming of dual lead pacemaker system | 36 | $4,874 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $3,949 | $66 |
| Injection, regadenoson, 0.1 mg | 12 | $2,284 | None |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $2,095 | $72 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 48 | $1,222 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 48 | $720 | $14 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 38 | $644 | $11 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 26 | $527 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $459 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $424 | $28 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 15 | $356 | $10 |
| Infusion, normal saline solution, 250 cc | 70 | $292 | None |
2020: 22 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 222 | $60,760 | $68 |
| Return visit (30+ min) | 362 | $60,483 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 272 | $55,946 | $179 |
| Long return visit (40+ min) | 252 | $40,428 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 257 | $32,749 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 152 | $30,746 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 60 | $30,652 | $511 |
| New patient visit (60+ min) | 100 | $18,452 | $185 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 60 | $11,691 | $98 |
| Transitional care management services for problem of high complexity | 26 | $6,408 | $237 |
| Transitional care management services for problem of at least moderate complexity | 26 | $5,517 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $5,125 | $69 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 179 | $5,117 | $6 |
| Programming of dual lead pacemaker system | 30 | $3,827 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 55 | $3,633 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $1,934 | $67 |
| External ekg recording for more than 48 hours up to 21 days | 46 | $1,339 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 46 | $1,170 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 26 | $456 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $345 | $16 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 11 | $217 | $13 |
| Infusion, normal saline solution, 250 cc | 55 | $176 | None |
2019: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 271 | $83,163 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 333 | $76,729 | $178 |
| Return visit (30+ min) | 438 | $71,322 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 321 | $38,959 | $93 |
| Long return visit (40+ min) | 262 | $37,644 | $119 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 74 | $36,501 | $493 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $36,008 | $189 |
| New patient visit (60+ min) | 130 | $22,471 | $173 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 73 | $13,265 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $9,333 | $63 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 207 | $5,570 | $6 |
| Programming of dual lead pacemaker system | 49 | $4,598 | $60 |
| Injection, regadenoson, 0.1 mg | 27 | $3,892 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 63 | $3,847 | $60 |
| Transitional care management services for problem of at least moderate complexity | 13 | $2,054 | $147 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 15 | $1,640 | $51 |
| Anticoagulant management of patient taking warfarin | 13 | $1,067 | $11 |
| External ekg recording for more than 48 hours up to 21 days | 36 | $996 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 35 | $846 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $287 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $213 | $16 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 21 | $122 | None |
| Infusion, normal saline solution, 250 cc | 64 | $88 | None |
2018: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 467 | $152,841 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 562 | $125,994 | $176 |
| Return visit (30+ min) | 453 | $79,759 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 552 | $65,400 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 98 | $47,410 | $479 |
| Long return visit (40+ min) | 228 | $34,466 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $34,135 | $192 |
| New patient visit (60+ min) | 97 | $15,460 | $159 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 98 | $9,788 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 133 | $8,822 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 63 | $4,144 | $63 |
| Programming of dual lead pacemaker system | 41 | $3,272 | $51 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 106 | $2,156 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,650 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $1,604 | $47 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 16 | $1,452 | $91 |
| Injection, regadenoson, 0.1 mg | 21 | $1,064 | None |
| Hospital discharge day management, 30 minutes or less | 11 | $1,038 | $65 |
| Programming of single lead pacemaker system | 13 | $661 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $501 | $15 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 37 | $22 | None |
2017: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 502 | $158,922 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 626 | $143,607 | $176 |
| Return visit (30+ min) | 484 | $94,100 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 613 | $77,622 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 92 | $45,198 | $486 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 155 | $34,520 | $217 |
| Long return visit (40+ min) | 151 | $18,413 | $112 |
| New patient visit (60+ min) | 97 | $16,604 | $171 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $8,966 | $56 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 92 | $8,621 | $93 |
| Programming of dual lead pacemaker system | 49 | $3,817 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $3,299 | $69 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $1,971 | $58 |
| Injection, regadenoson, 0.1 mg | 44 | $1,909 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,705 | $81 |
| Programming of single lead pacemaker system | 13 | $863 | $41 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $352 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $298 | $15 |
| Infusion, normal saline solution, 250 cc | 79 | $32 | None |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 27 | $12 | None |
2016: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 546 | $158,421 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 682 | $153,774 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 673 | $93,910 | $89 |
| Return visit (30+ min) | 477 | $89,143 | $87 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 61 | $29,055 | $476 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 141 | $28,669 | $200 |
| Long return visit (40+ min) | 205 | $25,832 | $108 |
| New patient visit (60+ min) | 91 | $15,094 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $9,851 | $54 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 60 | $6,472 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 81 | $5,479 | $68 |
| Programming of dual lead pacemaker system | 50 | $4,118 | $50 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,644 | $78 |
| Injection, regadenoson, 0.1 mg | 16 | $1,440 | None |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $1,333 | $58 |
| Programming of single lead pacemaker system | 18 | $1,242 | $44 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,136 | $63 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 22 | $536 | $6 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 26 | $438 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $341 | $24 |
| Infusion, normal saline solution, 250 cc | 59 | $22 | None |
2015: 27 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 565 | $128,357 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 443 | $125,975 | $62 |
| Return visit (30+ min) | 454 | $89,393 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 548 | $77,823 | $90 |
| Long return visit (40+ min) | 214 | $32,363 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $30,696 | $210 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 51 | $24,948 | $480 |
| New patient visit (60+ min) | 104 | $17,484 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $10,389 | $54 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $6,597 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 80 | $5,602 | $68 |
| Programming of dual lead pacemaker system | 52 | $4,310 | $50 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $3,796 | $292 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 19 | $2,689 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,674 | $76 |
| Hospital discharge day management, 30 minutes or less | 29 | $2,305 | $64 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 15 | $1,631 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $1,311 | $69 |
| Programming of single lead pacemaker system | 17 | $1,065 | $44 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 25 | $972 | None |
| Insertion of needle or tube into artery of arm or leg | 18 | $811 | $45 |
| Review by radiologist of arm or leg artery image | 16 | $743 | $46 |
| Injection for imaging of aorta above heart valve with review by radiologist | 17 | $734 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 47 | $606 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $464 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $174 | $16 |
| Infusion, normal saline solution, 250 cc | 53 | $17 | None |
2014: 26 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 321 | $110,934 | $63 |
| Return visit (30+ min) | 500 | $99,665 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 380 | $88,933 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 372 | $48,483 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 72 | $34,238 | $476 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 156 | $34,157 | $213 |
| Long return visit (40+ min) | 147 | $20,214 | $122 |
| New patient visit (60+ min) | 98 | $16,295 | $166 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 71 | $9,185 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 158 | $8,835 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 92 | $6,539 | $70 |
| Programming of dual lead pacemaker system | 64 | $5,325 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 25 | $3,462 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 36 | $2,876 | $80 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 49 | $2,842 | None |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $2,484 | $65 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,540 | $64 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 11 | $1,424 | $119 |
| Programming of single lead pacemaker system | 21 | $1,026 | $38 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 47 | $612 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $603 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $545 | $24 |
| Insertion of needle or tube into artery of arm or leg | 11 | $480 | $44 |
| Administration of influenza virus vaccine | 15 | $444 | $30 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 15 | $126 | $8 |
| Infusion, normal saline solution, 250 cc | 73 | $18 | None |
2013: 27 services
| Return visit (30+ min) | 507 | $113,913 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 201 | $70,675 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 231 | $59,220 | $171 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 98 | $47,982 | $490 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 220 | $32,335 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 171 | $30,262 | $174 |
| New patient visit (60+ min) | 132 | $22,788 | $173 |
| Long return visit (40+ min) | 123 | $14,736 | $115 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 98 | $12,304 | $67 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 78 | $11,753 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $10,038 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $8,326 | $51 |
| Programming of dual lead pacemaker system | 65 | $4,585 | $46 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 42 | $3,595 | $86 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,372 | $259 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 20 | $3,115 | $59 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 115 | $2,688 | $6 |
| Hospital discharge day management, 30 minutes or less | 28 | $2,408 | $63 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $1,661 | $62 |
| Programming of single lead pacemaker system | 22 | $1,581 | $43 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 15 | $1,521 | $101 |
| Review by radiologist of arm or leg artery image | 15 | $697 | $46 |
| Insertion of needle or tube into artery of arm or leg | 15 | $643 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $547 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $238 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $189 | $17 |
| Infusion, normal saline solution, 250 cc | 66 | $15 | None |
Medicaid work
$3,912 in 2024
Medicaid paid $3,912 for 1,125 billed services this clinician did in 2024, up to 151 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 967 | $2,023 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 158 | $1,889 |
| 2024 | 1,125 | 2 | 151 | $3,912 |
| 2023 | 994 | 2 | 146 | $4,912 |
| 2022 | 637 | 2 | 117 | $5,101 |
| 2021 | 459 | 4 | 103 | $2,507 |
| 2020 | 138 | 1 | 34 | $1,500 |
| 2019 | 36 | 1 | 24 | $266 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 205 | $2,823 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 789 | $2,089 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 570 | $3,236 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 67 | $1,864 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 334 | $2,507 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $0 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 93 | $0 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $0 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 138 | $1,500 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 36 | $266 |
Drugs they prescribed that Part D paid
$1,087,562
Pharmacies billed $1,087,562 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (17 of 4,716) in 2024. A higher opioid share than 9 in 10 peers; the typical cardiology clinician is at 0%.
3,689 generic and fewer than 11 brand-name prescriptions · $1,087,562 in drug cost · 37 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 267 | $320,277 | $1,200 |
| Xarelto | 138 | $165,119 | $1,197 |
| Jardiance | 107 | $138,407 | $1,294 |
| Repatha Sureclick | 117 | $83,823 | $716 |
| Entresto | 45 | $58,319 | $1,296 |
See all 75 drugs
| Eliquis | 267 | $320,277 | $1,200 |
| Xarelto | 138 | $165,119 | $1,197 |
| Jardiance | 107 | $138,407 | $1,294 |
| Repatha Sureclick | 117 | $83,823 | $716 |
| Entresto | 45 | $58,319 | $1,296 |
| Ozempic | 49 | $45,815 | $935 |
| Farxiga | 46 | $40,593 | $882 |
| Praluent | 43 | $24,510 | $570 |
| Trelegy Ellipta | 23 | $22,057 | $959 |
| Mounjaro | 13 | $14,356 | $1,104 |
| Trintellix | 17 | $11,319 | $666 |
| Trulicity | 13 | $10,773 | $829 |
| Vascepa | 15 | $8,020 | $535 |
| Ezetimibe | 150 | $4,461 | $30 |
| Olmesartan-Hydrochlorothiazide | 59 | $4,105 | $70 |
| Diltiazem 24hr Er (Cd) | 80 | $3,638 | $45 |
| Atorvastatin | 369 | $3,536 | $10 |
| Nebivolol | 50 | $3,312 | $66 |
| Olmesartan Medoxomil | 115 | $3,274 | $28 |
| Flecainide Acetate | 48 | $2,904 | $61 |
| Bisoprolol | 98 | $2,840 | $29 |
| Metoprolol | 150 | $2,585 | $17 |
| Amlodipine Besylate | 302 | $2,439 | $8 |
| Valsartan | 111 | $2,311 | $21 |
| Losartan | 213 | $2,221 | $10 |
| Spironolactone | 172 | $1,969 | $11 |
| Bumetanide | 49 | $1,542 | $31 |
| Amiodarone | 80 | $1,498 | $19 |
| Valsartan-Hydrochlorothiazide | 36 | $1,476 | $41 |
| Duloxetine | 13 | $1,215 | $93 |
| Torsemide | 65 | $1,208 | $19 |
| Midodrine | 12 | $951 | $79 |
| Pantoprazole | 41 | $940 | $23 |
| Rosuvastatin | 48 | $922 | $19 |
| Sotalol | 55 | $874 | $16 |
| Lisinopril | 70 | $723 | $10 |
| Nifedipine Er | 23 | $703 | $31 |
| Nitroglycerin | 39 | $651 | $17 |
| Hydrocodone-Acetaminophen | 17 | $650 | $38 |
| Pravastatin | 52 | $588 | $11 |
| Tamsulosin | 42 | $572 | $14 |
| Levothyroxine | 50 | $495 | $10 |
| Clopidogrel | 42 | $427 | $10 |
| Potassium Chloride | 13 | $423 | $33 |
| Simvastatin | 25 | $406 | $16 |
| Gabapentin | 35 | $366 | $10 |
| Losartan-Hydrochlorothiazide | 27 | $365 | $14 |
| Digoxin | 19 | $362 | $19 |
| Albuterol Sulfate Hfa | 13 | $359 | $28 |
| Furosemide | 63 | $310 | $5 |
| Propafenone Hcl Er | 13 | $298 | $23 |
| Isosorbide Mononitrate Er | 19 | $292 | $15 |
| Metoprolol | 23 | $276 | $12 |
| Montelukast | 13 | $249 | $19 |
| Carvedilol | 41 | $237 | $6 |
| Allopurinol | 52 | $235 | $5 |
| Clonidine | 23 | $215 | $9 |
| Atenolol | 29 | $177 | $6 |
| Trazodone | 24 | $163 | $7 |
| Hydrochlorothiazide | 24 | $162 | $7 |
| Omeprazole | 15 | $151 | $10 |
| Labetalol | 11 | $149 | $14 |
| Fluticasone Propionate | 20 | $146 | $7 |
| Zolpidem | 12 | $144 | $12 |
| Famotidine | 15 | $143 | $10 |
| Metformin | 40 | $136 | $3 |
| Sertraline | 14 | $134 | $10 |
| Triamterene-Hydrochlorothiazid | 12 | $131 | $11 |
| Meclizine | 13 | $96 | $7 |
| Lorazepam | 29 | $95 | $3 |
| Escitalopram | 19 | $73 | $4 |
| Meloxicam | 35 | $72 | $2 |
| Diazepam | 14 | $52 | $4 |
| Warfarin | 25 | $34 | $1 |
| Amoxicillin | 11 | $32 | $3 |
Year by year
| 2024 | 4,716 | 446 | 0% (17) | None | $1,087,562 |
| 2023 | 4,710 | 435 | 0% (21) | 19% | $968,805 |
| 2022 | 4,388 | 425 | 0% (17) | None | $762,838 |
| 2021 | 4,356 | 393 | None | None | $729,239 |
| 2020 | 4,370 | 386 | 1% (31) | None | $605,351 |
| 2019 | 4,182 | 375 | 1% (56) | None | $504,252 |
| 2018 | 4,406 | 369 | 1% (60) | None | $422,678 |
| 2017 | 4,374 | 345 | 1% (41) | 20% | $371,954 |
| 2016 | 4,644 | 353 | 1% (47) | 24% | $388,868 |
| 2015 | 4,849 | 352 | 1% (54) | None | $337,973 |
| 2014 | 4,848 | 344 | 2% (84) | None | $290,690 |
| 2013 | 4,983 | 332 | 1% (70) | 26% | $260,066 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 71 drugs
| Eliquis | 235 | $269,721 | $1,148 |
| Xarelto | 114 | $145,060 | $1,272 |
| Jardiance | 74 | $104,312 | $1,410 |
| Repatha Sureclick | 103 | $75,995 | $738 |
| Farxiga | 49 | $46,197 | $943 |
| Entresto | 33 | $41,691 | $1,263 |
| Praluent | 43 | $25,126 | $584 |
| Multaq | 13 | $18,705 | $1,439 |
| Trelegy Ellipta | 15 | $15,590 | $1,039 |
| Trintellix | 17 | $12,575 | $740 |
| Trulicity | 12 | $11,734 | $978 |
| Vascepa | 22 | $11,493 | $522 |
| Ezetimibe | 136 | $8,051 | $59 |
| Nebivolol | 70 | $7,687 | $110 |
| Olmesartan Medoxomil | 114 | $7,479 | $66 |
| Diltiazem 24hr Er (Cd) | 117 | $5,301 | $45 |
| Atorvastatin | 356 | $4,957 | $14 |
| Amiodarone | 98 | $4,852 | $50 |
| Bisoprolol | 112 | $4,174 | $37 |
| Losartan | 224 | $3,535 | $16 |
| Valsartan | 91 | $3,279 | $36 |
| Amlodipine Besylate | 328 | $3,240 | $10 |
| Flecainide Acetate | 59 | $3,160 | $54 |
| Metoprolol | 166 | $3,036 | $18 |
| Spironolactone | 168 | $2,264 | $13 |
| Rosuvastatin | 52 | $1,891 | $36 |
| Nifedipine Er | 35 | $1,876 | $54 |
| Bumetanide | 47 | $1,837 | $39 |
| Torsemide | 90 | $1,677 | $19 |
| Propafenone Hcl Er | 14 | $1,364 | $97 |
| Duloxetine | 13 | $1,141 | $88 |
| Olmesartan-Hydrochlorothiazide | 28 | $1,101 | $39 |
| Levothyroxine | 70 | $1,093 | $16 |
| Tamsulosin | 54 | $1,082 | $20 |
| Sotalol | 47 | $1,072 | $23 |
| Lisinopril | 77 | $929 | $12 |
| Pantoprazole | 43 | $893 | $21 |
| Losartan-Hydrochlorothiazide | 32 | $877 | $27 |
| Propranolol | 12 | $858 | $71 |
| Pravastatin | 56 | $821 | $15 |
| Simvastatin | 33 | $813 | $25 |
| Potassium Chloride | 22 | $813 | $37 |
| Valsartan-Hydrochlorothiazide | 23 | $763 | $33 |
| Gabapentin | 48 | $748 | $16 |
| Allopurinol | 40 | $664 | $17 |
| Clopidogrel | 39 | $663 | $17 |
| Isosorbide Mononitrate Er | 37 | $646 | $17 |
| Hydrocodone-Acetaminophen | 17 | $638 | $38 |
| Clonidine | 23 | $598 | $26 |
| Carvedilol | 53 | $573 | $11 |
| Warfarin | 36 | $566 | $16 |
| Omeprazole | 17 | $430 | $25 |
| Furosemide | 46 | $419 | $9 |
| Metformin | 47 | $399 | $8 |
| Metoprolol | 32 | $379 | $12 |
| Montelukast | 11 | $313 | $28 |
| Triamterene-Hydrochlorothiazid | 21 | $302 | $14 |
| Nitroglycerin | 20 | $285 | $14 |
| Carisoprodol | 11 | $280 | $25 |
| Atenolol | 28 | $266 | $10 |
| Doxazosin Mesylate | 14 | $214 | $15 |
| Ramipril | 13 | $214 | $16 |
| Trazodone | 29 | $208 | $7 |
| Hydralazine | 13 | $177 | $14 |
| Meloxicam | 34 | $161 | $5 |
| Lorazepam | 23 | $137 | $6 |
| Paxlovid (Eua) | 11 | $116 | $11 |
| Diazepam | 12 | $105 | $9 |
| Hydrochlorothiazide | 15 | $96 | $6 |
| Sertraline | 13 | $88 | $7 |
| Escitalopram | 17 | $46 | $3 |
2022: 72 drugs
| Eliquis | 176 | $200,521 | $1,139 |
| Xarelto | 111 | $135,782 | $1,223 |
| Repatha Sureclick | 98 | $66,744 | $681 |
| Jardiance | 42 | $57,458 | $1,368 |
| Entresto | 39 | $44,883 | $1,151 |
| Praluent | 46 | $24,523 | $533 |
| Farxiga | 25 | $19,271 | $771 |
| Rybelsus | 11 | $14,259 | $1,296 |
| Trintellix | 22 | $11,380 | $517 |
| Bystolic | 21 | $10,048 | $478 |
| Vascepa | 19 | $7,285 | $383 |
| Nebivolol | 59 | $6,963 | $118 |
| Amiodarone | 115 | $6,031 | $52 |
| Valsartan | 112 | $5,215 | $47 |
| Ezetimibe | 71 | $5,135 | $72 |
| Olmesartan Medoxomil | 68 | $4,928 | $72 |
| Bisoprolol | 103 | $3,979 | $39 |
| Diltiazem 24hr Er (Cd) | 84 | $3,820 | $45 |
| Flecainide Acetate | 55 | $3,519 | $64 |
| Metoprolol | 152 | $3,490 | $23 |
| Atorvastatin | 304 | $3,345 | $11 |
| Losartan | 218 | $2,957 | $14 |
| Amlodipine Besylate | 344 | $2,377 | $7 |
| Potassium Chloride | 13 | $1,870 | $144 |
| Rosuvastatin | 62 | $1,797 | $29 |
| Bumetanide | 40 | $1,792 | $45 |
| Torsemide | 89 | $1,777 | $20 |
| Spironolactone | 166 | $1,702 | $10 |
| Olmesartan-Hydrochlorothiazide | 26 | $1,518 | $58 |
| Levothyroxine | 80 | $1,488 | $19 |
| Celecoxib | 14 | $1,440 | $103 |
| Nifedipine Er | 23 | $1,251 | $54 |
| Pravastatin | 72 | $1,094 | $15 |
| Propafenone | 14 | $1,021 | $73 |
| Valsartan-Hydrochlorothiazide | 26 | $999 | $38 |
| Propranolol | 11 | $921 | $84 |
| Losartan-Hydrochlorothiazide | 41 | $902 | $22 |
| Isosorbide Mononitrate Er | 28 | $830 | $30 |
| Tamsulosin | 42 | $769 | $18 |
| Pantoprazole | 51 | $743 | $15 |
| Warfarin | 38 | $671 | $18 |
| Albuterol Sulfate Hfa | 20 | $667 | $33 |
| Allopurinol | 36 | $588 | $16 |
| Sotalol | 26 | $564 | $22 |
| Nitroglycerin | 21 | $553 | $26 |
| Omeprazole | 20 | $484 | $24 |
| Carvedilol | 51 | $459 | $9 |
| Simvastatin | 31 | $452 | $15 |
| Lisinopril | 59 | $450 | $8 |
| Gabapentin | 44 | $440 | $10 |
| Furosemide | 75 | $434 | $6 |
| Hydrocodone-Acetaminophen | 12 | $412 | $34 |
| Metformin | 44 | $402 | $9 |
| Escitalopram | 28 | $312 | $11 |
| Clopidogrel | 23 | $293 | $13 |
| Triamterene-Hydrochlorothiazid | 18 | $276 | $15 |
| Lisinopril-Hydrochlorothiazide | 12 | $260 | $22 |
| Clonidine | 23 | $219 | $10 |
| Atenolol | 26 | $191 | $7 |
| Hydrochlorothiazide | 30 | $190 | $6 |
| Montelukast | 13 | $176 | $14 |
| Metoprolol | 24 | $163 | $7 |
| Doxazosin Mesylate | 12 | $136 | $11 |
| Quetiapine | 13 | $133 | $10 |
| Meloxicam | 26 | $121 | $5 |
| Trazodone | 25 | $121 | $5 |
| Prednisone | 13 | $117 | $9 |
| Lorazepam | 17 | $101 | $6 |
| Diazepam | 17 | $88 | $5 |
| Zolpidem | 13 | $71 | $5 |
| Sertraline | 18 | $60 | $3 |
| Amoxicillin | 13 | $19 | $1 |
2021: 73 drugs
| Xarelto | 144 | $158,074 | $1,098 |
| Eliquis | 165 | $151,494 | $918 |
| Entresto | 63 | $53,749 | $853 |
| Jardiance | 37 | $46,527 | $1,257 |
| Repatha Sureclick | 76 | $44,571 | $586 |
| Bystolic | 81 | $35,369 | $437 |
| Farxiga | 37 | $20,689 | $559 |
| Praluent | 41 | $20,371 | $497 |
| Vascepa | 26 | $10,186 | $392 |
| Trintellix | 23 | $10,178 | $443 |
| Pradaxa | 15 | $8,595 | $573 |
| Olmesartan Medoxomil | 63 | $6,472 | $103 |
| Bisoprolol | 94 | $4,915 | $52 |
| Atorvastatin | 306 | $4,594 | $15 |
| Ezetimibe | 52 | $4,506 | $87 |
| Flecainide Acetate | 64 | $4,483 | $70 |
| Diltiazem 24hr Er (Cd) | 79 | $4,407 | $56 |
| Amiodarone | 86 | $3,921 | $46 |
| Olmesartan-Hydrochlorothiazide | 48 | $3,768 | $78 |
| Losartan | 179 | $3,154 | $18 |
| Rosuvastatin | 59 | $2,886 | $49 |
| Metoprolol | 143 | $2,757 | $19 |
| Bumetanide | 52 | $2,586 | $50 |
| Valsartan | 55 | $2,556 | $46 |
| Propafenone | 18 | $2,530 | $141 |
| Amlodipine Besylate | 326 | $2,425 | $7 |
| Nebivolol | 11 | $2,390 | $217 |
| Valsartan-Hydrochlorothiazide | 28 | $1,913 | $68 |
| Levothyroxine | 91 | $1,751 | $19 |
| Spironolactone | 148 | $1,621 | $11 |
| Losartan-Hydrochlorothiazide | 41 | $1,240 | $30 |
| Isosorbide Mononitrate Er | 40 | $1,137 | $28 |
| Pravastatin | 51 | $974 | $19 |
| Allopurinol | 46 | $933 | $20 |
| Digoxin | 17 | $922 | $54 |
| Warfarin | 32 | $856 | $27 |
| Torsemide | 54 | $806 | $15 |
| Albuterol Sulfate Hfa | 16 | $796 | $50 |
| Pantoprazole | 49 | $773 | $16 |
| Potassium Chloride | 37 | $700 | $19 |
| Furosemide | 88 | $645 | $7 |
| Tamsulosin | 42 | $641 | $15 |
| Fenofibrate | 12 | $604 | $50 |
| Sotalol | 38 | $585 | $15 |
| Carvedilol | 43 | $582 | $14 |
| Nitroglycerin | 29 | $527 | $18 |
| Gabapentin | 51 | $490 | $10 |
| Clonidine | 31 | $481 | $16 |
| Omeprazole | 47 | $474 | $10 |
| Simvastatin | 33 | $450 | $14 |
| Doxazosin Mesylate | 19 | $443 | $23 |
| Lisinopril | 49 | $430 | $9 |
| Triamterene-Hydrochlorothiazid | 33 | $412 | $12 |
| Clopidogrel | 27 | $386 | $14 |
| Atenolol | 30 | $353 | $12 |
| Metformin | 36 | $314 | $9 |
| Verapamil Er | 12 | $311 | $26 |
| Trazodone | 23 | $287 | $12 |
| Montelukast | 17 | $281 | $17 |
| Hydrochlorothiazide | 36 | $224 | $6 |
| Metoprolol | 39 | $207 | $5 |
| Meclizine | 15 | $204 | $14 |
| Quetiapine | 16 | $182 | $11 |
| Escitalopram | 15 | $167 | $11 |
| Alprazolam | 11 | $165 | $15 |
| Ramipril | 12 | $149 | $12 |
| Lisinopril-Hydrochlorothiazide | 13 | $126 | $10 |
| Lorazepam | 20 | $106 | $5 |
| Diazepam | 13 | $92 | $7 |
| Zolpidem | 13 | $77 | $6 |
| Alendronate | 15 | $49 | $3 |
| Sertraline | 14 | $28 | $2 |
| Amoxicillin | 11 | $19 | $2 |
2020: 83 drugs
| Xarelto | 171 | $145,694 | $852 |
| Eliquis | 125 | $86,703 | $694 |
| Entresto | 62 | $52,286 | $843 |
| Bystolic | 96 | $34,847 | $363 |
| Repatha Sureclick | 51 | $29,190 | $572 |
| Jardiance | 19 | $14,536 | $765 |
| Praluent | 31 | $14,171 | $457 |
| Trintellix | 31 | $12,363 | $399 |
| Symbicort | 14 | $7,926 | $566 |
| Vascepa | 23 | $7,787 | $339 |
| Olmesartan Medoxomil | 74 | $7,329 | $99 |
| Pradaxa | 15 | $7,147 | $476 |
| Diltiazem 24hr Er (Cd) | 88 | $6,015 | $68 |
| Farxiga | 11 | $5,792 | $527 |
| Brilinta | 13 | $5,140 | $395 |
| Edarbi | 21 | $4,514 | $215 |
| Atorvastatin | 272 | $4,461 | $16 |
| Flecainide Acetate | 64 | $4,121 | $64 |
| Ezetimibe | 41 | $3,585 | $87 |
| Amiodarone | 93 | $3,479 | $37 |
| Olmesartan-Hydrochlorothiazide | 53 | $3,135 | $59 |
| Losartan | 175 | $2,994 | $17 |
| Bisoprolol | 70 | $2,916 | $42 |
| Losartan-Hydrochlorothiazide | 40 | $2,798 | $70 |
| Bumetanide | 73 | $2,798 | $38 |
| Rosuvastatin | 53 | $2,708 | $51 |
| Metoprolol | 138 | $2,650 | $19 |
| Levothyroxine | 109 | $2,416 | $22 |
| Amlodipine Besylate | 311 | $1,979 | $6 |
| Pravastatin | 78 | $1,710 | $22 |
| Propafenone | 21 | $1,630 | $78 |
| Valsartan | 21 | $1,557 | $74 |
| Isosorbide Mononitrate Er | 51 | $1,269 | $25 |
| Metolazone | 19 | $1,248 | $66 |
| Potassium Chloride | 53 | $1,210 | $23 |
| Nifedipine Er | 15 | $1,038 | $69 |
| Warfarin | 60 | $1,004 | $17 |
| Valsartan-Hydrochlorothiazide | 13 | $951 | $73 |
| Digoxin | 21 | $936 | $45 |
| Spironolactone | 84 | $904 | $11 |
| Prasugrel | 14 | $832 | $59 |
| Pantoprazole | 55 | $824 | $15 |
| Allopurinol | 43 | $820 | $19 |
| Simvastatin | 67 | $813 | $12 |
| Nitroglycerin | 30 | $765 | $26 |
| Furosemide | 99 | $715 | $7 |
| Fenofibrate | 15 | $680 | $45 |
| Albuterol Sulfate Hfa | 16 | $659 | $41 |
| Clonidine | 48 | $635 | $13 |
| Tamsulosin | 30 | $619 | $21 |
| Carvedilol | 51 | $577 | $11 |
| Doxazosin Mesylate | 19 | $564 | $30 |
| Clopidogrel | 43 | $526 | $12 |
| Verapamil Er | 17 | $524 | $31 |
| Metformin | 49 | $520 | $11 |
| Hydrochlorothiazide | 47 | $465 | $10 |
| Lisinopril | 51 | $429 | $8 |
| Cyclobenzaprine | 21 | $388 | $18 |
| Triamterene-Hydrochlorothiazid | 36 | $368 | $10 |
| Atenolol | 30 | $366 | $12 |
| Sotalol | 19 | $364 | $19 |
| Omeprazole | 22 | $341 | $15 |
| Meclizine | 23 | $290 | $13 |
| Quetiapine | 14 | $270 | $19 |
| Gabapentin | 36 | $267 | $7 |
| Lorazepam | 30 | $244 | $8 |
| Metoprolol | 32 | $243 | $8 |
| Meloxicam | 16 | $226 | $14 |
| Hydrocodone-Acetaminophen | 12 | $225 | $19 |
| Alprazolam | 14 | $205 | $15 |
| Quinapril | 13 | $202 | $16 |
| Trazodone | 21 | $199 | $9 |
| Montelukast | 11 | $156 | $14 |
| Escitalopram | 12 | $142 | $12 |
| Diazepam | 14 | $135 | $10 |
| Levofloxacin | 13 | $125 | $10 |
| Sertraline | 19 | $110 | $6 |
| Fluticasone Propionate | 11 | $105 | $10 |
| Glipizide | 15 | $93 | $6 |
| Tramadol | 19 | $83 | $4 |
| Ramipril | 13 | $80 | $6 |
| Carisoprodol | 12 | $73 | $6 |
| Alendronate | 13 | $35 | $3 |
2019: 81 drugs
| Xarelto | 141 | $111,465 | $791 |
| Eliquis | 93 | $65,456 | $704 |
| Bystolic | 121 | $37,348 | $309 |
| Entresto | 42 | $28,109 | $669 |
| Repatha Sureclick | 19 | $18,387 | $968 |
| Trintellix | 42 | $16,463 | $392 |
| Praluent | 12 | $10,129 | $844 |
| Olmesartan Medoxomil | 69 | $8,090 | $117 |
| Pradaxa | 18 | $7,962 | $442 |
| Olmesartan-Hydrochlorothiazide | 68 | $6,677 | $98 |
| Ranolazine Er | 12 | $5,930 | $494 |
| Flecainide Acetate | 58 | $5,282 | $91 |
| Metoprolol | 141 | $4,588 | $33 |
| Diltiazem 24hr Er (Cd) | 69 | $4,575 | $66 |
| Amiodarone | 68 | $3,774 | $56 |
| Rosuvastatin | 50 | $3,320 | $66 |
| Atorvastatin | 194 | $3,095 | $16 |
| Amlodipine-Olmesartan | 18 | $2,813 | $156 |
| Losartan | 174 | $2,523 | $14 |
| Bisoprolol | 38 | $2,388 | $63 |
| Amlodipine Besylate | 299 | $2,295 | $8 |
| Pravastatin | 67 | $1,708 | $25 |
| Levothyroxine | 77 | $1,570 | $20 |
| Isosorbide Mononitrate Er | 66 | $1,477 | $22 |
| Warfarin | 94 | $1,300 | $14 |
| Propafenone | 22 | $1,258 | $57 |
| Furosemide | 144 | $1,097 | $8 |
| Nifedipine Er | 20 | $1,072 | $54 |
| Valsartan-Hydrochlorothiazide | 13 | $1,065 | $82 |
| Ventolin Hfa | 18 | $1,046 | $58 |
| Cartia Xt | 19 | $1,035 | $54 |
| Losartan-Hydrochlorothiazide | 69 | $1,013 | $15 |
| Clopidogrel | 66 | $997 | $15 |
| Bumetanide | 28 | $932 | $33 |
| Allopurinol | 38 | $905 | $24 |
| Potassium Chloride | 40 | $898 | $22 |
| Prasugrel | 19 | $890 | $47 |
| Omeprazole | 46 | $845 | $18 |
| Digoxin | 12 | $828 | $69 |
| Labetalol | 19 | $808 | $43 |
| Pantoprazole | 38 | $787 | $21 |
| Simvastatin | 56 | $778 | $14 |
| Ezetimibe | 11 | $743 | $68 |
| Doxazosin Mesylate | 17 | $732 | $43 |
| Midodrine | 12 | $700 | $58 |
| Gabapentin | 44 | $678 | $15 |
| Tamsulosin | 30 | $653 | $22 |
| Hydrocodone-Acetaminophen | 27 | $649 | $24 |
| Lisinopril | 64 | $633 | $10 |
| Valsartan | 19 | $628 | $33 |
| Carvedilol | 60 | $618 | $10 |
| Spironolactone | 68 | $599 | $9 |
| Clonidine | 51 | $575 | $11 |
| Sotalol | 32 | $573 | $18 |
| Quetiapine | 21 | $517 | $25 |
| Verapamil Er | 12 | $468 | $39 |
| Triamterene-Hydrochlorothiazid | 40 | $454 | $11 |
| Lorazepam | 43 | $425 | $10 |
| Metoprolol | 48 | $399 | $8 |
| Atenolol | 37 | $381 | $10 |
| Metformin | 45 | $373 | $8 |
| Nitroglycerin | 20 | $346 | $17 |
| Fenofibrate | 14 | $343 | $24 |
| Fluticasone Propionate | 27 | $319 | $12 |
| Lovastatin | 12 | $285 | $24 |
| Benazepril | 18 | $276 | $15 |
| Trazodone | 20 | $240 | $12 |
| Glipizide | 22 | $236 | $11 |
| Hydrochlorothiazide | 21 | $235 | $11 |
| Mirtazapine | 16 | $230 | $14 |
| Meclizine | 20 | $217 | $11 |
| Montelukast | 17 | $194 | $11 |
| Ramipril | 11 | $184 | $17 |
| Sertraline | 22 | $175 | $8 |
| Diclofenac | 12 | $155 | $13 |
| Tramadol | 29 | $139 | $5 |
| Glimepiride | 16 | $124 | $8 |
| Diazepam | 11 | $89 | $8 |
| Amlodipine Besylate-Benazepril | 13 | $80 | $6 |
| Amoxicillin | 17 | $32 | $2 |
| Alendronate | 12 | $18 | $2 |
2018: 83 drugs
| Xarelto | 91 | $59,491 | $654 |
| Eliquis | 94 | $56,923 | $606 |
| Multaq | 28 | $36,752 | $1,313 |
| Bystolic | 139 | $32,481 | $234 |
| Ranexa | 22 | $14,710 | $669 |
| Pradaxa | 25 | $12,460 | $498 |
| Trintellix | 26 | $11,589 | $446 |
| Entresto | 18 | $8,505 | $473 |
| Olmesartan-Hydrochlorothiazide | 53 | $5,001 | $94 |
| Flecainide Acetate | 62 | $4,975 | $80 |
| Olmesartan Medoxomil | 65 | $4,260 | $66 |
| Symbicort | 14 | $4,223 | $302 |
| Prasugrel | 18 | $3,890 | $216 |
| Diltiazem 24hr Er (Cd) | 67 | $3,479 | $52 |
| Rosuvastatin | 53 | $3,135 | $59 |
| Metoprolol | 101 | $3,006 | $30 |
| Atorvastatin | 171 | $2,797 | $16 |
| Pravastatin | 88 | $2,536 | $29 |
| Amlodipine-Olmesartan | 14 | $2,422 | $173 |
| Amiodarone | 77 | $2,232 | $29 |
| Amlodipine Besylate | 292 | $1,877 | $6 |
| Isosorbide Mononitrate Er | 95 | $1,706 | $18 |
| Warfarin | 105 | $1,639 | $16 |
| Clobetasol Propionate | 12 | $1,579 | $132 |
| Levothyroxine | 84 | $1,506 | $18 |
| Valsartan | 52 | $1,437 | $28 |
| Losartan | 147 | $1,435 | $10 |
| Digoxin | 18 | $1,373 | $76 |
| Bisoprolol | 31 | $1,372 | $44 |
| Nitroglycerin | 35 | $1,362 | $39 |
| Hydrocodone-Acetaminophen | 47 | $1,330 | $28 |
| Cartia Xt | 33 | $1,265 | $38 |
| Bumetanide | 39 | $1,188 | $30 |
| Cholestyramine | 15 | $1,172 | $78 |
| Potassium Chloride | 38 | $1,139 | $30 |
| Losartan-Hydrochlorothiazide | 77 | $1,020 | $13 |
| Propafenone | 30 | $1,016 | $34 |
| Doxazosin Mesylate | 20 | $956 | $48 |
| Nifedipine Er | 15 | $906 | $60 |
| Furosemide | 139 | $902 | $6 |
| Allopurinol | 45 | $897 | $20 |
| Gabapentin | 72 | $885 | $12 |
| Simvastatin | 79 | $884 | $11 |
| Tamsulosin | 43 | $806 | $19 |
| Metolazone | 15 | $804 | $54 |
| Pantoprazole | 59 | $779 | $13 |
| Omeprazole | 55 | $761 | $14 |
| Labetalol | 14 | $761 | $54 |
| Clopidogrel | 53 | $707 | $13 |
| Carvedilol | 100 | $699 | $7 |
| Digox | 13 | $681 | $52 |
| Quetiapine | 23 | $636 | $28 |
| Lisinopril | 71 | $615 | $9 |
| Ventolin Hfa | 11 | $601 | $55 |
| Triamterene-Hydrochlorothiazid | 57 | $581 | $10 |
| Metoprolol | 76 | $508 | $7 |
| Spironolactone | 61 | $493 | $8 |
| Metformin | 55 | $461 | $8 |
| Sotalol | 28 | $419 | $15 |
| Verapamil Er | 30 | $417 | $14 |
| Valsartan-Hydrochlorothiazide | 11 | $403 | $37 |
| Alprazolam | 23 | $392 | $17 |
| Meclizine | 15 | $389 | $26 |
| Clonidine | 52 | $310 | $6 |
| Atenolol | 46 | $289 | $6 |
| Lorazepam | 43 | $263 | $6 |
| Glipizide | 26 | $251 | $10 |
| Escitalopram | 14 | $222 | $16 |
| Fenofibrate | 13 | $208 | $16 |
| Finasteride | 11 | $175 | $16 |
| Levofloxacin | 15 | $140 | $9 |
| Zolpidem | 15 | $136 | $9 |
| Diazepam | 13 | $115 | $9 |
| Ramipril | 15 | $109 | $7 |
| Lovastatin | 11 | $104 | $9 |
| Sertraline | 12 | $94 | $8 |
| Glimepiride | 24 | $94 | $4 |
| Amlodipine Besylate-Benazepril | 15 | $94 | $6 |
| Hydrochlorothiazide | 16 | $91 | $6 |
| Alendronate | 22 | $85 | $4 |
| Diclofenac | 12 | $77 | $6 |
| Clonazepam | 11 | $48 | $4 |
| Amoxicillin | 18 | $26 | $1 |
2017: 85 drugs
| Eliquis | 74 | $40,021 | $541 |
| Xarelto | 47 | $31,222 | $664 |
| Bystolic | 158 | $28,602 | $181 |
| Multaq | 14 | $18,573 | $1,327 |
| Pradaxa | 39 | $17,817 | $457 |
| Effient | 24 | $14,279 | $595 |
| Ranexa | 24 | $12,938 | $539 |
| Androgel | 11 | $12,340 | $1,122 |
| Olmesartan-Hydrochlorothiazide | 56 | $12,200 | $218 |
| Advair Diskus | 18 | $10,427 | $579 |
| Entresto | 14 | $6,023 | $430 |
| Benicar Hct | 15 | $5,780 | $385 |
| Olmesartan Medoxomil | 49 | $5,412 | $110 |
| Nexium | 13 | $5,375 | $413 |
| Rosuvastatin | 49 | $4,709 | $96 |
| Trintellix | 13 | $4,591 | $353 |
| Flecainide Acetate | 67 | $3,374 | $50 |
| Olmesartan-Amlodipine-Hctz | 16 | $2,878 | $180 |
| Mometasone Furoate | 12 | $2,754 | $229 |
| Atorvastatin | 172 | $2,649 | $15 |
| Pravastatin | 90 | $2,568 | $29 |
| Valsartan | 70 | $2,172 | $31 |
| Metoprolol | 66 | $1,898 | $29 |
| Amlodipine-Olmesartan | 11 | $1,888 | $172 |
| Amlodipine Besylate | 305 | $1,795 | $6 |
| Levothyroxine | 118 | $1,775 | $15 |
| Propafenone | 33 | $1,761 | $53 |
| Losartan | 167 | $1,575 | $9 |
| Warfarin | 102 | $1,511 | $15 |
| Isosorbide Mononitrate Er | 88 | $1,344 | $15 |
| Cholestyramine | 17 | $1,315 | $77 |
| Digoxin | 20 | $1,209 | $60 |
| Nifedipine Er | 30 | $1,175 | $39 |
| Nitroglycerin | 36 | $1,160 | $32 |
| Potassium Chloride | 26 | $1,123 | $43 |
| Furosemide | 149 | $1,003 | $7 |
| Diltiazem 24hr Er | 32 | $979 | $31 |
| Pantoprazole | 49 | $974 | $20 |
| Bisoprolol | 30 | $916 | $31 |
| Amiodarone | 72 | $916 | $13 |
| Losartan-Hydrochlorothiazide | 55 | $884 | $16 |
| Labetalol | 19 | $832 | $44 |
| Gabapentin | 72 | $816 | $11 |
| Carvedilol | 124 | $815 | $7 |
| Allopurinol | 52 | $807 | $16 |
| Spironolactone | 67 | $745 | $11 |
| Omeprazole | 56 | $739 | $13 |
| Simvastatin | 76 | $724 | $10 |
| Hydrocodone-Acetaminophen | 29 | $707 | $24 |
| Digox | 21 | $703 | $33 |
| Lisinopril | 86 | $698 | $8 |
| Cartia Xt | 34 | $674 | $20 |
| Metolazone | 12 | $630 | $53 |
| Doxazosin Mesylate | 28 | $584 | $21 |
| Valsartan-Hydrochlorothiazide | 17 | $577 | $34 |
| Fenofibrate | 15 | $547 | $36 |
| Tamsulosin | 29 | $535 | $18 |
| Atenolol | 92 | $508 | $6 |
| Metformin | 45 | $507 | $11 |
| Meclizine | 16 | $504 | $31 |
| Metoprolol | 67 | $492 | $7 |
| Verapamil Er | 26 | $470 | $18 |
| Sotalol | 49 | $454 | $9 |
| Verapamil Sr | 12 | $428 | $36 |
| Lorazepam | 51 | $428 | $8 |
| Carbidopa-Levodopa | 13 | $375 | $29 |
| Quetiapine | 14 | $371 | $26 |
| Triamterene-Hydrochlorothiazid | 43 | $366 | $9 |
| Levofloxacin | 23 | $358 | $16 |
| Diltiazem Er | 12 | $345 | $29 |
| Clopidogrel | 32 | $325 | $10 |
| Escitalopram | 16 | $300 | $19 |
| Digitek | 12 | $292 | $24 |
| Glipizide | 35 | $285 | $8 |
| Alprazolam | 15 | $268 | $18 |
| Diclofenac | 19 | $220 | $12 |
| Lovastatin | 12 | $207 | $17 |
| Lisinopril-Hydrochlorothiazide | 19 | $203 | $11 |
| Amlodipine Besylate-Benazepril | 16 | $155 | $10 |
| Clonidine | 19 | $155 | $8 |
| Hydrochlorothiazide | 17 | $133 | $8 |
| Zolpidem | 20 | $101 | $5 |
| Alendronate | 23 | $99 | $4 |
| Glimepiride | 20 | $78 | $4 |
| Temazepam | 12 | $66 | $6 |
2016: 90 drugs
| Benicar Hct | 86 | $29,894 | $348 |
| Xarelto | 49 | $27,421 | $560 |
| Eliquis | 66 | $27,387 | $415 |
| Multaq | 32 | $26,612 | $832 |
| Pradaxa | 42 | $19,863 | $473 |
| Crestor | 49 | $19,800 | $404 |
| Bystolic | 115 | $18,126 | $158 |
| Effient | 41 | $16,962 | $414 |
| Tribenzor | 34 | $11,779 | $346 |
| Advair Diskus | 18 | $11,466 | $637 |
| Azor | 30 | $10,530 | $351 |
| Androgel | 12 | $9,719 | $810 |
| Benicar | 24 | $9,309 | $388 |
| Nexium | 18 | $7,483 | $416 |
| Ranexa | 15 | $6,294 | $420 |
| Januvia | 12 | $4,398 | $366 |
| Pravastatin | 82 | $2,755 | $34 |
| Tekturna | 13 | $2,464 | $190 |
| Janumet Xr | 13 | $2,422 | $186 |
| Atorvastatin | 154 | $2,298 | $15 |
| Rosuvastatin | 19 | $2,292 | $121 |
| Amlodipine Besylate | 322 | $2,265 | $7 |
| Levothyroxine | 132 | $2,078 | $16 |
| Digoxin | 49 | $2,018 | $41 |
| Propafenone | 42 | $1,805 | $43 |
| Warfarin | 176 | $1,757 | $10 |
| Metformin Hcl Er | 18 | $1,638 | $91 |
| Losartan | 176 | $1,623 | $9 |
| Hydrocodone-Acetaminophen | 41 | $1,541 | $38 |
| Flecainide Acetate | 57 | $1,496 | $26 |
| Isosorbide Mononitrate Er | 76 | $1,336 | $18 |
| Metoprolol | 41 | $1,292 | $32 |
| Valsartan | 30 | $1,245 | $41 |
| Potassium Chloride | 38 | $1,149 | $30 |
| Nifedipine Er | 39 | $1,081 | $28 |
| Digox | 22 | $994 | $45 |
| Amiodarone | 74 | $989 | $13 |
| Bisoprolol | 23 | $941 | $41 |
| Omeprazole | 79 | $940 | $12 |
| Carvedilol | 113 | $936 | $8 |
| Lisinopril | 121 | $914 | $8 |
| Diltiazem 24hr Er | 22 | $911 | $41 |
| Cholestyramine | 18 | $885 | $49 |
| Furosemide | 164 | $826 | $5 |
| Losartan-Hydrochlorothiazide | 68 | $796 | $12 |
| Sotalol | 55 | $790 | $14 |
| Simvastatin | 82 | $746 | $9 |
| Doxazosin Mesylate | 24 | $729 | $30 |
| Allopurinol | 40 | $663 | $17 |
| Tamsulosin | 35 | $632 | $18 |
| Pantoprazole | 31 | $629 | $20 |
| Atenolol | 125 | $626 | $5 |
| Verapamil Er | 36 | $625 | $17 |
| Escitalopram | 13 | $621 | $48 |
| Gabapentin | 72 | $607 | $8 |
| Fenofibrate | 26 | $592 | $23 |
| Fenofibrate | 24 | $585 | $24 |
| Labetalol | 18 | $574 | $32 |
| Spironolactone | 63 | $563 | $9 |
| Cartia Xt | 20 | $543 | $27 |
| Metoprolol | 67 | $541 | $8 |
| Valsartan-Hydrochlorothiazide | 38 | $528 | $14 |
| Metformin | 60 | $499 | $8 |
| Verapamil Sr | 12 | $490 | $41 |
| Meclizine | 16 | $449 | $28 |
| Nitrostat | 11 | $405 | $37 |
| Triamterene-Hydrochlorothiazid | 50 | $404 | $8 |
| Glipizide | 31 | $390 | $13 |
| Lorazepam | 41 | $370 | $9 |
| Diltiazem Er | 11 | $337 | $31 |
| Lisinopril-Hydrochlorothiazide | 29 | $294 | $10 |
| Cimetidine | 11 | $292 | $27 |
| Gemfibrozil | 16 | $230 | $14 |
| Amlodipine Besylate-Benazepril | 17 | $225 | $13 |
| Levetiracetam | 15 | $224 | $15 |
| Alprazolam | 22 | $219 | $10 |
| Quetiapine | 11 | $205 | $19 |
| Alendronate | 35 | $193 | $6 |
| Clonazepam | 34 | $192 | $6 |
| Sertraline | 17 | $177 | $10 |
| Lovastatin | 14 | $177 | $13 |
| Clopidogrel | 19 | $165 | $9 |
| Zolpidem | 38 | $150 | $4 |
| Donepezil | 11 | $142 | $13 |
| Hydrochlorothiazide | 15 | $125 | $8 |
| Temazepam | 15 | $89 | $6 |
| Pioglitazone | 13 | $89 | $7 |
| Clonidine | 12 | $85 | $7 |
| Cyclobenzaprine | 11 | $42 | $4 |
| Glimepiride | 11 | $34 | $3 |
2015: 90 drugs
| Multaq | 43 | $30,765 | $715 |
| Benicar Hct | 77 | $25,996 | $338 |
| Xarelto | 55 | $24,194 | $440 |
| Crestor | 64 | $22,239 | $347 |
| Eliquis | 55 | $20,723 | $377 |
| Pradaxa | 48 | $19,999 | $417 |
| Bystolic | 93 | $13,494 | $145 |
| Azor | 41 | $12,702 | $310 |
| Effient | 33 | $10,648 | $323 |
| Nexium | 25 | $9,531 | $381 |
| Tribenzor | 34 | $8,953 | $263 |
| Benicar | 32 | $8,717 | $272 |
| Advair Diskus | 15 | $7,757 | $517 |
| Ranexa | 14 | $6,048 | $432 |
| Combivent Respimat | 14 | $5,335 | $381 |
| Januvia | 13 | $4,353 | $335 |
| Tekturna | 16 | $3,640 | $227 |
| Diovan | 13 | $2,690 | $207 |
| Pravastatin | 91 | $2,638 | $29 |
| Flecainide Acetate | 54 | $2,486 | $46 |
| Propafenone | 44 | $2,342 | $53 |
| Atorvastatin | 149 | $2,229 | $15 |
| Warfarin | 187 | $2,118 | $11 |
| Levothyroxine | 122 | $2,070 | $17 |
| Valsartan | 29 | $2,048 | $71 |
| Amlodipine Besylate | 332 | $1,971 | $6 |
| Digoxin | 48 | $1,960 | $41 |
| Amiodarone | 90 | $1,731 | $19 |
| Diltiazem 24hr Er | 19 | $1,730 | $91 |
| Edarbyclor | 12 | $1,719 | $143 |
| Hydrocodone-Acetaminophen | 51 | $1,645 | $32 |
| Losartan | 214 | $1,616 | $8 |
| Valsartan-Hydrochlorothiazide | 38 | $1,420 | $37 |
| Potassium Chloride | 57 | $1,354 | $24 |
| Proair Hfa | 26 | $1,337 | $51 |
| Metoprolol | 41 | $1,331 | $32 |
| Isosorbide Mononitrate Er | 79 | $1,136 | $14 |
| Carvedilol | 138 | $988 | $7 |
| Toprol Xl | 17 | $966 | $57 |
| Cholestyramine | 14 | $900 | $64 |
| Losartan-Hydrochlorothiazide | 85 | $868 | $10 |
| Omeprazole | 79 | $867 | $11 |
| Doxazosin Mesylate | 30 | $856 | $29 |
| Digox | 21 | $804 | $38 |
| Labetalol | 26 | $788 | $30 |
| Atenolol | 160 | $761 | $5 |
| Diltiazem Er | 28 | $760 | $27 |
| Nifedipine Er | 30 | $744 | $25 |
| Lisinopril | 113 | $726 | $6 |
| Allopurinol | 51 | $693 | $14 |
| Metformin Hcl Er | 17 | $672 | $40 |
| Verapamil Er | 33 | $655 | $20 |
| Verapamil Sr | 14 | $612 | $44 |
| Furosemide | 143 | $609 | $4 |
| Fenofibrate | 25 | $596 | $24 |
| Simvastatin | 93 | $595 | $6 |
| Sotalol | 54 | $564 | $10 |
| Pantoprazole | 33 | $562 | $17 |
| Metformin | 79 | $551 | $7 |
| Lisinopril-Hydrochlorothiazide | 63 | $547 | $9 |
| Spironolactone | 83 | $540 | $7 |
| Zolpidem | 52 | $529 | $10 |
| Bisoprolol | 22 | $519 | $24 |
| Fenofibrate | 12 | $507 | $42 |
| Tamsulosin | 37 | $504 | $14 |
| Synthroid | 11 | $422 | $38 |
| Nitrostat | 21 | $398 | $19 |
| Triamterene-Hydrochlorothiazid | 42 | $287 | $7 |
| Metoprolol | 52 | $258 | $5 |
| Lorazepam | 25 | $250 | $10 |
| Gabapentin | 56 | $234 | $4 |
| Lovastatin | 17 | $186 | $11 |
| Glipizide | 30 | $172 | $6 |
| Nifedical Xl | 12 | $165 | $14 |
| Alendronate | 26 | $161 | $6 |
| Torsemide | 19 | $149 | $8 |
| Levofloxacin | 12 | $138 | $12 |
| Levetiracetam | 12 | $124 | $10 |
| Clopidogrel | 17 | $122 | $7 |
| Hydrochlorothiazide | 25 | $121 | $5 |
| Sertraline | 21 | $109 | $5 |
| Alprazolam | 15 | $105 | $7 |
| Pioglitazone | 13 | $103 | $8 |
| Citalopram Hbr | 11 | $90 | $8 |
| Gemfibrozil | 11 | $89 | $8 |
| Clonidine | 14 | $89 | $6 |
| Donepezil | 13 | $84 | $6 |
| Cephalexin | 11 | $63 | $6 |
| Clonazepam | 24 | $60 | $3 |
| Temazepam | 11 | $48 | $4 |
2014: 97 drugs
| Xarelto | 59 | $20,260 | $343 |
| Pradaxa | 47 | $17,903 | $381 |
| Multaq | 26 | $15,727 | $605 |
| Benicar Hct | 41 | $15,244 | $372 |
| Crestor | 57 | $13,846 | $243 |
| Azor | 56 | $12,849 | $229 |
| Eliquis | 35 | $11,675 | $334 |
| Benicar | 45 | $10,309 | $229 |
| Diovan | 55 | $9,101 | $165 |
| Bystolic | 73 | $8,822 | $121 |
| Advair Diskus | 19 | $6,867 | $361 |
| Nexium | 17 | $6,207 | $365 |
| Ranexa | 19 | $5,813 | $306 |
| Combivent Respimat | 19 | $5,287 | $278 |
| Januvia | 16 | $4,651 | $291 |
| Hydrocodone-Acetaminophen | 77 | $4,644 | $60 |
| Tribenzor | 17 | $4,067 | $239 |
| Atorvastatin | 199 | $3,165 | $16 |
| Tekturna | 18 | $3,160 | $176 |
| Warfarin | 203 | $2,449 | $12 |
| Amlodipine Besylate | 316 | $2,419 | $8 |
| Losartan | 214 | $2,177 | $10 |
| Pravastatin | 78 | $2,175 | $28 |
| Metoprolol | 57 | $2,057 | $36 |
| Metformin Hcl Er | 17 | $2,043 | $120 |
| Levothyroxine | 124 | $2,002 | $16 |
| Propafenone | 38 | $1,974 | $52 |
| Flecainide Acetate | 51 | $1,840 | $36 |
| Digoxin | 46 | $1,749 | $38 |
| Amiodarone | 55 | $1,625 | $30 |
| Fenofibrate | 14 | $1,620 | $116 |
| Tarka | 12 | $1,616 | $135 |
| Nifedipine Er | 26 | $1,569 | $60 |
| Losartan-Hydrochlorothiazide | 122 | $1,533 | $13 |
| Carvedilol | 142 | $1,377 | $10 |
| Valsartan-Hydrochlorothiazide | 36 | $1,346 | $37 |
| Isosorbide Mononitrate Er | 70 | $1,317 | $19 |
| Proair Hfa | 27 | $1,311 | $49 |
| Toprol Xl | 23 | $1,301 | $57 |
| Edarbyclor | 11 | $1,272 | $116 |
| Potassium Chloride | 26 | $1,203 | $46 |
| Omeprazole | 97 | $1,125 | $12 |
| Simvastatin | 121 | $976 | $8 |
| Atenolol | 171 | $965 | $6 |
| Sotalol | 78 | $887 | $11 |
| Taztia Xt | 16 | $868 | $54 |
| Diltiazem Er | 24 | $857 | $36 |
| Digox | 25 | $842 | $34 |
| Metformin | 105 | $764 | $7 |
| Pioglitazone | 12 | $761 | $63 |
| Fenofibrate | 23 | $696 | $30 |
| Pantoprazole | 24 | $679 | $28 |
| Spironolactone | 73 | $642 | $9 |
| Bisoprolol | 18 | $619 | $34 |
| Labetalol | 21 | $573 | $27 |
| Nifedical Xl | 14 | $564 | $40 |
| Lisinopril | 84 | $533 | $6 |
| Zolpidem | 58 | $522 | $9 |
| Lisinopril-Hydrochlorothiazide | 64 | $510 | $8 |
| Furosemide | 122 | $470 | $4 |
| Diltiazem 24hr Er | 22 | $455 | $21 |
| Verapamil Er | 25 | $390 | $16 |
| Nitrostat | 21 | $373 | $18 |
| Doxazosin Mesylate | 16 | $365 | $23 |
| Afeditab Cr | 11 | $339 | $31 |
| Allopurinol | 44 | $338 | $8 |
| Torsemide | 23 | $338 | $15 |
| Metoprolol | 62 | $336 | $5 |
| Carisoprodol | 13 | $322 | $25 |
| Tamsulosin | 26 | $320 | $12 |
| Verapamil Sr | 12 | $312 | $26 |
| Clotrimazole-Betamethasone | 15 | $308 | $21 |
| Diltiazem 24hr Cd | 14 | $302 | $22 |
| Escitalopram | 14 | $290 | $21 |
| Triamterene-Hydrochlorothiazid | 35 | $288 | $8 |
| Synthroid | 13 | $274 | $21 |
| Alendronate | 24 | $274 | $11 |
| Lovastatin | 23 | $271 | $12 |
| Clopidogrel | 13 | $249 | $19 |
| Lorazepam | 31 | $238 | $8 |
| Glipizide | 41 | $222 | $5 |
| Sertraline | 19 | $210 | $11 |
| Alprazolam | 24 | $196 | $8 |
| Ranitidine | 15 | $181 | $12 |
| Terazosin | 19 | $175 | $9 |
| Levofloxacin | 11 | $169 | $15 |
| Nystatin | 12 | $168 | $14 |
| Cimetidine | 12 | $157 | $13 |
| Clonidine | 21 | $125 | $6 |
| Clonazepam | 24 | $114 | $5 |
| Citalopram Hbr | 12 | $101 | $8 |
| Donepezil | 11 | $96 | $9 |
| Ramipril | 12 | $95 | $8 |
| Azithromycin | 14 | $94 | $7 |
| Hydrochlorothiazide | 17 | $87 | $5 |
| Gabapentin | 12 | $60 | $5 |
| Metoclopramide | 12 | $29 | $2 |
2013: 91 drugs
| Multaq | 51 | $18,794 | $369 |
| Pradaxa | 49 | $17,078 | $349 |
| Crestor | 61 | $12,717 | $208 |
| Azor | 56 | $11,276 | $201 |
| Diovan | 60 | $9,458 | $158 |
| Bystolic | 79 | $8,838 | $112 |
| Benicar | 46 | $8,562 | $186 |
| Androgel | 15 | $8,220 | $548 |
| Nexium | 20 | $7,431 | $372 |
| Xarelto | 25 | $6,956 | $278 |
| Advair Diskus | 19 | $6,899 | $363 |
| Atorvastatin | 236 | $6,710 | $28 |
| Ranexa | 25 | $6,186 | $247 |
| Januvia | 22 | $5,708 | $259 |
| Benicar Hct | 16 | $4,923 | $308 |
| Eliquis | 15 | $4,880 | $325 |
| Tribenzor | 22 | $4,792 | $218 |
| Losartan | 241 | $4,239 | $18 |
| Amlodipine Besylate | 348 | $3,197 | $9 |
| Combivent Respimat | 12 | $3,171 | $264 |
| Tekturna | 17 | $2,651 | $156 |
| Warfarin | 243 | $2,641 | $11 |
| Metoprolol | 65 | $2,547 | $39 |
| Tekturna Hct | 15 | $2,539 | $169 |
| Celebrex | 14 | $2,370 | $169 |
| Hydrocodone-Acetaminophen | 63 | $2,265 | $36 |
| Losartan-Hydrochlorothiazide | 173 | $2,256 | $13 |
| Vytorin | 12 | $1,971 | $164 |
| Clopidogrel | 45 | $1,816 | $40 |
| Valsartan-Hydrochlorothiazide | 35 | $1,814 | $52 |
| Carvedilol | 186 | $1,805 | $10 |
| Isosorbide Mononitrate Er | 101 | $1,731 | $17 |
| Nifedipine Er | 37 | $1,632 | $44 |
| Pantoprazole | 38 | $1,582 | $42 |
| Escitalopram | 19 | $1,575 | $83 |
| Propafenone | 28 | $1,547 | $55 |
| Diltiazem Er | 40 | $1,459 | $36 |
| Pioglitazone | 12 | $1,438 | $120 |
| Amlodipine Besylate-Benazepril | 24 | $1,341 | $56 |
| Tarka | 11 | $1,317 | $120 |
| Toprol Xl | 22 | $1,285 | $58 |
| Potassium Chloride | 22 | $1,211 | $55 |
| Amiodarone | 40 | $1,160 | $29 |
| Omeprazole | 87 | $1,150 | $13 |
| Simvastatin | 127 | $1,140 | $9 |
| Taztia Xt | 17 | $1,072 | $63 |
| Pravastatin | 60 | $1,011 | $17 |
| Levothyroxine | 110 | $1,007 | $9 |
| Atenolol | 177 | $1,005 | $6 |
| Labetalol | 28 | $943 | $34 |
| Sotalol | 66 | $940 | $14 |
| Verapamil Er | 41 | $894 | $22 |
| Proair Hfa | 19 | $890 | $47 |
| Spironolactone | 70 | $817 | $12 |
| Nifedical Xl | 12 | $751 | $63 |
| Fenofibrate | 22 | $749 | $34 |
| Lisinopril | 117 | $737 | $6 |
| Metformin | 96 | $710 | $7 |
| Nifediac Cc | 12 | $705 | $59 |
| Furosemide | 154 | $575 | $4 |
| Torsemide | 38 | $542 | $14 |
| Lisinopril-Hydrochlorothiazide | 52 | $510 | $10 |
| Levetiracetam | 19 | $428 | $23 |
| Alendronate | 35 | $400 | $11 |
| Metoprolol | 63 | $383 | $6 |
| Lovastatin | 27 | $373 | $14 |
| Diltiazem 24hr Er | 18 | $365 | $20 |
| Terazosin | 32 | $304 | $10 |
| Digox | 31 | $268 | $9 |
| Tamsulosin | 19 | $258 | $14 |
| Triamterene-Hctz | 24 | $255 | $11 |
| Clonidine | 30 | $254 | $8 |
| Hydralazine | 13 | $247 | $19 |
| Nitrostat | 16 | $245 | $15 |
| Zolpidem | 38 | $240 | $6 |
| Glipizide | 33 | $229 | $7 |
| Allopurinol | 24 | $226 | $9 |
| Fluoxetine | 12 | $207 | $17 |
| Lorazepam | 20 | $193 | $10 |
| Klor-Con M10 | 14 | $193 | $14 |
| Alprazolam | 24 | $177 | $7 |
| Donepezil | 12 | $177 | $15 |
| Metformin Hcl Er | 12 | $164 | $14 |
| Ranitidine | 12 | $144 | $12 |
| Hydrochlorothiazide | 21 | $132 | $6 |
| Ramipril | 11 | $126 | $11 |
| Citalopram Hbr | 17 | $119 | $7 |
| Gabapentin | 13 | $104 | $8 |
| Temazepam | 11 | $89 | $8 |
| Diazepam | 15 | $82 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $73 | $6 |
Money from drug and device companies
$701 in 2025
| 2025 | 9 | 31 | None | $701 |
| 2024 | 13 | 49 | None | $1,079 |
| 2023 | 11 | 63 | None | $1,568 |
| 2022 | 10 | 51 | None | $1,040 |
| 2021 | 5 | 20 | None | $473 |
| 2020 | 6 | 22 | None | $391 |
| 2019 | 11 | 51 | None | $1,060 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Eliquis | $184 | 11 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $180 | 3 payments
|
| Amgen | Repatha | $96 | 4 payments
|
| Pfizer | Eliquis | $81 | 4 payments
|
| Novo Nordisk | Wegovy | $74 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $26 | 1 payment
|
See all 30 published payments
| Amgen | Meals · 2025-12-17 | Repatha | $26 |
| Pfizer | Meals · 2025-12-01 | Eliquis | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-24 | Eliquis | $13 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-18 | Jardiance | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-30 | Eliquis | $22 |
| Novo Nordisk | Meals · 2025-10-08 | Wegovy | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-26 | Eliquis | $15 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Leqvio | $26 |
| Pfizer | Meals · 2025-08-20 | Eliquis | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-15 | Eliquis | $14 |
| Amgen | Meals · 2025-08-13 | Repatha | $23 |
| Pfizer | Meals · 2025-07-29 | Eliquis | $21 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-24 | Jardiance | $123 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-22 | Eliquis | $28 |
| Novo Nordisk | Meals · 2025-07-17 | Wegovy | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-08 | Eliquis | $13 |
| Pfizer | Meals · 2025-06-11 | Eliquis | $20 |
| Merck Sharp & Dohme | Meals · 2025-05-29 | Verquvo | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-15 | Camzyos | $12 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-07 | Jardiance | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-06 | Eliquis | $5 |
| Amgen | Meals · 2025-04-29 | Repatha | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-22 | Eliquis | $30 |
| Esperion Therapeutics | Meals · 2025-03-28 | Nexletol | $15 |
| Novo Nordisk | Meals · 2025-03-24 | Ozempic | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-12 | Eliquis | $10 |
| Novo Nordisk | Meals · 2025-02-28 | Ozempic | $18 |
| Amgen | Meals · 2025-01-28 | Repatha | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-21 | Camzyos | $22 |
| Boston Scientific | Meals · 2025-01-14 | Watchman Flx | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,079
| E.R. Squibb & Sons L.L.C. | Camzyos | $311 | 13 payments
|
| Amgen | Repatha | $245 | 13 payments
|
| Novartis Pharmaceuticals | Entresto | $121 | 5 payments
|
| Boston Scientific | Watchman Flx | $87 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $47 | 2 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $47 | 2 payments
|
| Pfizer | Eliquis | $47 | 2 payments
|
| Esperion Therapeutics | Nexletol | $45 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Abbott Laboratories | Jot Dx | $18 | 1 payment
|
| GlaxoSmithKline | Arexvy | $17 | 1 payment
|
2023: $1,568
| E.R. Squibb & Sons L.L.C. | Camzyos | $345 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $295 | 13 payments
|
| Boston Scientific | Watchman Flx | $245 | 6 payments
|
| Amgen | Repatha | $154 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $154 | 8 payments
|
| Merck Sharp & Dohme | Verquvo | $147 | 2 payments
|
| Pfizer | Eliquis | $64 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $58 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $51 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $33 | 1 payment
|
| Abbott Laboratories | Mitraclip | $22 | 1 payment
|
2022: $1,040
| E.R. Squibb & Sons L.L.C. | Eliquis | $319 | 13 payments
|
| Janssen Pharmaceuticals | Xarelto | $195 | 13 payments
|
| Merck Sharp & Dohme | Verquvo | $133 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $131 | 11 payments
|
| Amgen | Repatha | $114 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $69 | 3 payments
|
| Pfizer | Eliquis | $30 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $24 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $17 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $7 | 1 payment
|
2021: $473
| Amgen | Repatha | $190 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $151 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $72 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $45 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $15 | 1 payment
|
2020: $391
| Amgen | Repatha | $194 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $86 | 8 payments
|
| Novartis Pharmaceuticals | Entresto | $43 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $31 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $16 | 1 payment
|
2019: $1,060
| Pfizer | Vyndaqel | $314 | 18 payments
|
| Janssen Pharmaceuticals | Xarelto | $154 | 7 payments
|
| Amgen | Repatha | $132 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $131 | 9 payments
|
| Portola Pharmaceuticals | Andexxa | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $45 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $40 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $39 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $31 | 2 payments
|
| Gilead Sciences | None | $28 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $21 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation TherapyAs Medicare defines this measure | 100% | 119 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery PatientsAs Medicare defines this measure | 0% | 48 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk PatientsAs Medicare defines this measure | 0% | 48 |
| Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 100% | 37 |
| Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 100% | 34 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 2,471 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Offers telehealth visits
Professional record
- NPI
- 1255312005
- Licence
- CA A56256, LA 10025RCalifornia A56256: Current · expires 2028-01-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2020 Forest Ave Ste. 3, San Jose, CA, 95128
- NPI first listed
- 2005-11-09
- NPI last updated
- 2023-05-06
- NPI record certified
- 2023-05-06
This is when the NPI record was last certified, not a medical board exam.